Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers

Overview of attention for article published in Cancer Cell, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

patent: 8 patents

Readers on

mendeley: 147 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugs

Grant US-12162932-B2

United States of America

10 Dec 2024

ANTI-NETRIN-1 MONOCLONAL ANTIBODY FOR TREATING ENDOMETRIOSIS AND ASSOCIATED PAINS

Application WO-2024180085-A1

World Intellectual Property Organisation (WIPO)

06 Sep 2024

NOVEL MCL-1 INHIBITOR AND COMBINATION OF MCL-1 AND A BH3 MIMETIC, SUCH AS A BCL-2…

Application WO-2023186968-A1

World Intellectual Property Organisation (WIPO)

05 Oct 2023

ANTI-NETRIN-1 ANTIBODY TO TREAT LIVER INFLAMMATION

Application EP-4245772-A1

European Patent Office

20 Sep 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.